The Effects of Axitinib plus Tislelizumab in the Treatment of Advanced Renal Cell Carcinoma

Table 1

Renal function (x ± s).

Groups	n	BUN		SCr
		Before treatment	After treatment	Before treatment	After treatment
Study group	22	17.44 ± 0.87	3.27 ± 0.52	114.24 ± 13.57	64.81 ± 6.19
Control group	27	17.21 ± 0.83	5.14 ± 0.53	114.13 ± 13.26	78.36 ± 7.13
t		0.944	12.388	0.029	7.622
value		0.35	<0.001	0.977	<0.001